Average Co-Inventor Count = 9.98
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (14 from 3,935 patents)
14 patents:
1. 12466808 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors
2. 11530213 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
3. 10947218 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors
4. 10844055 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
5. 10710980 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors
6. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
7. 10463653 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
8. 10266531 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
9. 10130629 - Pharmaceutical combinations
10. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
11. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
12. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
13. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
14. 8815926 - Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases